VitaNova Life Sciences Corp (VNOV) › Shareholders' EquityVitaNova Life Sciences Corp (VNOV) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$3.7K2018: $42.2K2019: -$50.2K2020: -$122.6K2021: -$174.7K2022: -$35.0K2023: -$59.2K2024: $1.06M2025: $1.91M$1.91M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$1.91M+80.8%2024$1.06M+1883.2%2023-$59.2K-69.2%2022-$35.0K+80.0%2021-$174.7K-42.5%2020-$122.6K-144.0%2019-$50.2K-219.2%2018$42.2K+1247.1%2017-$3.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share